CELLINI, ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 344
EU - Europa 285
NA - Nord America 281
AF - Africa 141
SA - Sud America 125
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 1.194
Nazione #
US - Stati Uniti d'America 222
SG - Singapore 83
IT - Italia 75
BR - Brasile 74
CN - Cina 49
HK - Hong Kong 49
DE - Germania 42
VN - Vietnam 25
FI - Finlandia 15
PL - Polonia 11
AR - Argentina 10
BE - Belgio 10
EC - Ecuador 10
NL - Olanda 10
VE - Venezuela 9
AO - Angola 8
FR - Francia 8
IN - India 8
RU - Federazione Russa 8
SA - Arabia Saudita 8
SN - Senegal 8
BO - Bolivia 7
CD - Congo 7
CI - Costa d'Avorio 7
CY - Cipro 7
ES - Italia 7
GB - Regno Unito 7
NC - Nuova Caledonia 7
TR - Turchia 7
UG - Uganda 7
VC - Saint Vincent e Grenadine 7
AM - Armenia 6
CH - Svizzera 6
EE - Estonia 6
ID - Indonesia 6
MN - Mongolia 6
MR - Mauritania 6
PA - Panama 6
UA - Ucraina 6
AZ - Azerbaigian 5
BD - Bangladesh 5
BW - Botswana 5
BZ - Belize 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
GH - Ghana 5
GT - Guatemala 5
IE - Irlanda 5
IQ - Iraq 5
IR - Iran 5
KR - Corea 5
ML - Mali 5
MX - Messico 5
PK - Pakistan 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
ZA - Sudafrica 5
ZW - Zimbabwe 5
BY - Bielorussia 4
CV - Capo Verde 4
GF - Guiana Francese 4
GP - Guadalupe 4
HN - Honduras 4
HR - Croazia 4
IS - Islanda 4
JO - Giordania 4
LY - Libia 4
MG - Madagascar 4
MK - Macedonia 4
MU - Mauritius 4
MW - Malawi 4
MY - Malesia 4
RS - Serbia 4
SE - Svezia 4
TJ - Tagikistan 4
TL - Timor Orientale 4
UY - Uruguay 4
UZ - Uzbekistan 4
YE - Yemen 4
AT - Austria 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CG - Congo 3
CO - Colombia 3
CR - Costa Rica 3
CW - ???statistics.table.value.countryCode.CW??? 3
DZ - Algeria 3
GE - Georgia 3
IL - Israele 3
KE - Kenya 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LC - Santa Lucia 3
MZ - Mozambico 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
PH - Filippine 3
RO - Romania 3
SO - Somalia 3
Totale 1.102
Città #
Singapore 51
Ashburn 49
Hong Kong 45
Munich 29
Santa Clara 20
Chandler 19
Beijing 18
Padua 13
Buffalo 11
Los Angeles 9
Dakar 8
Hefei 8
Padova 8
Rio de Janeiro 8
Abidjan 7
Fairfield 7
Ho Chi Minh City 7
Kampala 7
Kingstown 7
Luanda 7
Noumea 7
Boardman 6
Kinshasa 6
Milan 6
Nouakchott 6
Panama City 6
Ulan Bator 6
Accra 5
Baku 5
Bamako 5
Dublin 5
Guayaquil 5
Hanoi 5
Harare 5
Turku 5
Yerevan 5
Amman 4
Ann Arbor 4
Antananarivo 4
Brussels 4
Dili 4
Gaborone 4
Lappeenranta 4
L’Aquila 4
Praia 4
Riyadh 4
Seattle 4
São Paulo 4
Tashkent 4
Tripoli 4
Belize City 3
Bratislava 3
Bytom 3
Cape Town 3
Castries 3
Dushanbe 3
Guangzhou 3
Helsinki 3
Houston 3
Lilongwe 3
Limassol 3
London 3
Maputo 3
Medford 3
Minsk 3
Nairobi 3
New York 3
Princeton 3
Reykjavik 3
Rome 3
Roxbury 3
San Diego 3
Sanaa 3
Santiago de los Caballeros 3
Tallinn 3
Tehran 3
Vienna 3
Woodbridge 3
Wroclaw 3
Zurich 3
Almaty 2
Andorra la Vella 2
Ankara 2
Apia 2
Atlanta 2
Auckland 2
Belgrade 2
Belmopan 2
Bologna 2
Borama 2
Boston 2
Brasília 2
Caracas 2
Catania 2
Chicago 2
Cochabamba 2
Coimbatore 2
Conakry 2
Cotonou 2
Dar es Salaam 2
Totale 612
Nome #
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance 157
Case Report: Triplet combination with pirtobrutinib/venetoclax/rituximab in accelerated phase of chronic lymphocytic leukemia 122
Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases 112
A Case of Hemophagocytic Lymphohistiocytosis Triggered by Disseminated Tuberculosis and Hairy Cell Leukaemia after SARS-CoV2 Infection 110
Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype 95
Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD 95
Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort 89
Incidence, prevention and management of severe infections in patients undergoing therapy for chronic lymphocytic leukemia 76
Persistent splenomegaly due to littoral cell angiomatosis in venetoclax-induced undetectable minimal residual disease of chronic lymphocytic leukemia 75
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency 71
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study 61
Richter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomes 60
Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study 34
Serum soluble interleukin-2 receptor levels in hairy cell leukaemia as a marker of tumour burden with prognostic value and as a tool for disease monitoring 28
Predicting thrombotic risk in patients with classical Hodgkin lymphoma: Thro‐HL multicenter study 23
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study 12
Totale 1.220
Categoria #
all - tutte 3.945
article - articoli 3.945
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.890


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202242 0 0 0 0 0 0 4 0 22 1 8 7
2022/202341 7 2 1 0 10 10 1 5 2 1 1 1
2023/202446 0 6 3 4 4 8 6 0 4 5 4 2
2024/2025305 4 5 6 0 25 8 13 23 32 26 60 103
2025/2026786 124 166 360 136 0 0 0 0 0 0 0 0
Totale 1.220